JPRN-jRCT2080222274未知3 期
Phase 3 study of S-888711 in thrombocytopenic patients with chronic liver disease
试验速览
- 阶段
- 3 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Main inclusion criteria:
- •Thrombocytopenic patients with chronic liver disease undergoing invasive procedures.
排除标准
- •Main exclusion criteria:
- •Patients who received blood transfusions (except for red blood cell products and albumin preparations) within 14 days prior to enrollment.
- •Patients who previously received TPO receptor agonists.
研究者
相似试验
未知
2 期
Phase 2 study of S-888711 in thrombocytopenic patients with chronic liver diseaseThrombocytopenic patients with chronic liver diseaseJPRN-jRCT2080221340SHIONOGI & CO., LTD.
未知
2 期
Phase 2b study of S-888711 in thrombocytopenic patients with chronic liver diseaseJPRN-jRCT2080221899SHIONOGI & CO., LTD.
未知
2 期
Phase 2 higher-dose study of S-888711 in thrombocytopenic patients with chronic liver diseaseJPRN-jRCT2080221585SHIONOGI & CO., LTD.
未知
3 期
A Phase 3b Open-label Study of S-888711 in Thrombocytopenic Patients with Chronic Liver DiseaseJPRN-jRCT2080222971Shionogi & Co., Ltd.
未知
1 期
A clinical pharmacology study of S-888711 in thrombocytopenic patients with Child-Pugh class C liver diseaseJPRN-jRCT2080223234Shionogi & Co., Ltd.